Saturday, February, 23, 2019 01:49:28

Category: Pharmaceuticals

CytoReason to collaborate with Pfizer on innovative drug discovery

The American company will be paying millions to CytoReason for its unparalleled models. CytoReason, the Israel based machine learning company, that is credited for developing immune system cell-centered models that necessarily aid in drug discovery, recently entered a collaboration with American pharmaceutical corporation, Pfizer Inc. …

Perlara, Rambam Medical Center tie up for kidney disease PerlQuest

Perlara, the U.S. based biotech public benefit corporation that is dedicated to discovering cures for rare diseases, recently announced a partnership with Rambam Medical Center in Israel and Dr. Karl Skorecki, a leading kidney disease researcher and nephrologist, to co-develop a PerlQuest into APOL1 kidney disease. For …